Healthcare & Pharmaceuticals · Royalcare Super Speciality Hospitals Unlisted / Pre-IPO Share Price
As of 28 Sept 2026, the Royalcare Super Speciality Hospitals unlisted share price is ₹155 per share. Royalcare Super Speciality Hospitals is an unlisted / pre-IPO company — not listed on NSE or BSE. ISIN: INE02C801010.
Key figures for Royalcare Super Speciality Hospitals
Royal Care Super Specialty Hospital began its journey as a 50-bed multi-specialty hospital on May 1, 2015, in Coimbatore, Tamil Nadu. Within a year, the hospital gained significant recognition for its quality of care, becoming a preferred healthcare destination for many in western Tamil Nadu. The hospital's commitment to excellence necessitated expansion, leading to the establishment of a larger and more comprehensive tertiary care unit.
Royalcare Super Speciality Hospitals shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. Royalcare Super Speciality Hospitals is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “Royalcare Super Speciality Hospitalsshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Royalcare Super Speciality Hospitals has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for Royalcare Super Speciality Hospitals is INE02C801010. Contact our desk for the latest status and a live quote before you invest.
Safal Capital tracks Royalcare Super Speciality Hospitals for pricing updates, liquidity context, and investor suitability.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
Solid Listing On Cards? SRIT India IPO GMP Signals 23% Gains As Issue Gets Fully Subscribed NDTV Profit
Srit India IPO fully bid on day 1 Business Standard
As of 28 Sept 2026, the Royalcare Super Speciality Hospitals unlisted (pre-IPO) share price is ₹155 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
You buy Royalcare Super Speciality Hospitals unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. Royalcare Super Speciality Hospitals is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Royalcare Super Speciality Hospitals has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on Royalcare Super Speciality Hospitals.
The ISIN for Royalcare Super Speciality Hospitals unlisted shares is INE02C801010. You will need this ISIN when the shares are credited to your demat account.
Royalcare Super Speciality Hospitals unlisted shares have a face value of ₹10 and a typical minimum lot of 1000 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The Royalcare Super Speciality Hospitals price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like Royalcare Super Speciality Hospitals can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess Royalcare Super Speciality Hospitals.
India's IPO pipeline hits Rs 3.86 lakh crore. What's driving the rush India Today
